Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063302

SVP & Chief Accounting Officer acquired 10,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2018-12-14 Grant or award +10,950 168,199 D
Derivatives
Thomsen Jillian B. SVP & Chief Accounting Officer 2018-12-14 Grant or award · Stock Option +22,150 22,150 D
Loading xslF345X03/doc4.xml…